Search | Médecins Sans Frontières Access Campaign

About us
About the Access Campaign

Some of our 2023 plans

Media room

Latest news

Jobs
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Our work
COVID-19

Explainer: A bold proposal at the WTO by India and South Africa

Diabetes

Drug-resistant infections

HIV/AIDS

Hepatitis C

Hypertension

Patents and intellectual property

Pandemic prevention, preparedness and response

The Patent Oppositions Database

Research and development

Spotlight on: the Big Pharma double-dip

Transparency Matters: Clinical Trials Costs

Tropical and neglected diseases

Spotlight on: Snakebite

Tuberculosis

Vaccines

Explainer: COVID-19 vaccines - Recommendations for equitable access
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Get involved
Campaign success stories

#NoMoreTears Johnson & Johnson Can you hear us?

A Fair Shot

Novartis 'Drop the case'

Trans-pacific Partnership (TPP)

Recent campaigns

Time for $5

No Patents in a Pandemic

Share the Tech - Save Lives
Take Action

Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.
Resources
Press releases

Statements

Letters

Opinion articles

Feature stories

Interviews

Blog

Newsletters

Publications

Research articles

Topic overview pages

Spotlight pages

Videos

Photo stories

Infographics

Events
Get Involved!
Sign up to stay updated and find out how you can get involved.

Email Address

Data protection consent

I want to receive emails from MSF and I have read and agree with the privacy policy.

Medicines shouldn’t be a luxury Take action!

6 results found
There are 2 active filters
Clear all filters
Republic of Korea
Uganda

6 results found

Vials of PCV13, a vaccine that protects children against pneumonia and meningitis. At 9 Euros a dose (three doses are necessary for the vaccine to be effective) PCV13 is currently priced at a rate much higher than most people in Central African Republic can afford. Photograph by Sandra Smiley

Press release |

06 February 2018

MSF challenges Pfizer’s monopoly on lifesaving pneumonia vaccine in Korea

Tags Intellectual property and tradeVaccines pneumococcal disease Republic of Korea

Thumbnail

Report |

23 April 2012

From the ground up: Building a drug-resistant TB programme in Uganda

Tags Intellectual property and tradeTuberculosis drug-resistant TBtuberculosis diagnostic tests Uganda

Research article |

27 July 2011

Life Expectancy of Persons Receiving Combination Antiretroviral Therapy in Low-Income Countries: A Cohort Analysis From Uganda

Tags HIV/AIDS HIV/AIDS antiretroviral medicines Uganda

Press release |

19 April 2011

Revolutionary Advance in Severe Malaria Treatment: Using Artesunate Instead Of Quinine Could Save 200,000 Lives Annually

Tags Malaria severe malaria quinineartesunate World Health Organization Uganda

Feature story |

24 September 2010

Protecting the next generation: PMTCT programme in Madi Opei, Northern Uganda

Tags HIV/AIDS HIV/AIDS Uganda

Thumbnail

Video |

23 September 2010

Protecting the next generation: PMTCT programme in Madi Opei, Northern Uganda

Tags HIV/AIDS HIV/AIDS Uganda